Jump to:
loading...| Preferred Name | Atazanavir | |
| Synonyms |
|
|
| Definitions |
An aza-dipeptide analogue with a bis-aryl substituent on the (hydroxethyl)hydrazine moiety with activity against both wild type and mutant forms of HIV protease. Atazanavir does not elevate serum lipids, a common problem with other protease inhibitors. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C66872 |
|
| CAS_Registry |
198904-31-3 |
|
| CHEBI_ID |
CHEBI:37924 |
|
| Chemical_Formula |
C38H52N6O7 |
|
| code |
C66872 |
|
| Contributing_Source |
FDA |
|
| definition |
An aza-dipeptide analogue with a bis-aryl substituent on the (hydroxethyl)hydrazine moiety with activity against both wild type and mutant forms of HIV protease. Atazanavir does not elevate serum lipids, a common problem with other protease inhibitors. |
|
| FDA_UNII_Code |
QZU4H47A3S |
|
| Has_Salt_Form | ||
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 |
|
| label |
Atazanavir |
|
| Legacy Concept Name |
Atazanavir_Base |
|
| Preferred_Name |
Atazanavir |
|
| prefixIRI |
NCIT:C66872 |
|
| prefLabel |
Atazanavir |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C1145759 |
|
| subClassOf |
Create mapping